Ikram H, Chan W, Bennett S I, Bones P J
Br Heart J. 1979 Sep;42(3):311-5. doi: 10.1136/hrt.42.3.311.
Acebutolol ('Sectral'), a cardioselective beta-blocking drug, was administered intravenously in a dose of 25 mg to 10 patients with congestive cardiomyopathy. All of them were in a stable condition on antifailure regimens. The drug resulted in a statistically significant decline in left ventricular contractility as judged by peak left ventricular dP/dT and the contractility index. The mean aortic blood pressure also fell. There was a significant increase in end-diastolic and end-systolic left ventricular volumes. Mean values for heart rate, ejection fraction, left ventricular stroke work index, and cardiac output also fell, but the results were not statistically significant. Left ventricular distensibility as judged by the slope of the diastolic pressure-volume relation also improved significantly. A reduction in myocardial energy requirements, improved compliance, and lowering of arterial pressure would be haemodynamically advantageous. However, further cardiac dilatation and reduction contractility--the basic defects in congestive cardiomyopathy--could lead to further deterioration.
醋丁洛尔(“心得静”)是一种心脏选择性β受体阻滞剂,以25毫克的剂量静脉注射给10名充血性心肌病患者。他们都在抗心力衰竭治疗方案下病情稳定。根据左心室dp/dt峰值和收缩性指数判断,该药导致左心室收缩性在统计学上显著下降。平均主动脉血压也下降。舒张末期和收缩末期左心室容积显著增加。心率、射血分数、左心室每搏功指数和心输出量的平均值也下降,但结果无统计学意义。根据舒张压-容积关系斜率判断的左心室扩张性也显著改善。心肌能量需求降低、顺应性改善和动脉压降低在血流动力学上是有利的。然而,进一步的心脏扩张和收缩性降低——充血性心肌病的基本缺陷——可能导致病情进一步恶化。